Figure 6

Long-time survivors have more DCs compared to short-time survivors. (A) Percent DCs of total PBMCs in healthy age match controls and pre tumor resection in PDAC patients surviving less than one year (short-time survivor) and more than two years survival (long-time survivor). (B and C) Comparison of the one year survival between the PDAC patient group with the lowest (N = 12) and highest (N = 12) levels of MDCs (≤0.25% and >0.25%) and PDCs (≤0.14% and >0.14%), respectively. (D) Percent DCs of total PBMCs in PDAC patients with more than two years survival (long-time survivor) and in patients with ampullary carcinoma (AC) and endocrine carcinoma (EC) patients. Statistically significant differences between individuals with pancreatic disease and healthy controls are indicated as; * =p < 0.05, *** = p < 0.001.